Literature DB >> 12859036

Randomized field trial of vaginal douching, pelvic inflammatory disease and pregnancy.

Kenneth J Rothman1, Donnie P Funch, Tanya Alfredson, Joanne Brady, Nancy A Dreyer.   

Abstract

BACKGROUND: Several case-control studies have reported that women who use vaginal douche products are at increased risk for pelvic inflammatory disease. Women who douche regularly may do so for reasons related to their risk of acquiring a sexually transmitted infection, introducing confounding that is difficult to control in non-experimental studies.
METHODS: We conducted a multicenter randomized field trial with a 1-year follow-up period. The study comprised 1827 women age 18-34, with no current indication of pelvic inflammatory disease, who were regular users of a douche product and who had been treated recently for a sexually transmitted bacterial infection or bacterial vaginosis. Women were randomly assigned to use either a newly designed and marketed douche product or a soft cloth towelette, and were resupplied with product at each bimonthly follow-up visit. We measured the occurrence of pelvic inflammatory disease using a combination of clinical and laboratory indicators. We also recorded pregnancy occurrence among participants.
RESULTS: The risk of PID among women assigned to use the douche product, relative to that among women assigned to use the wipe product, was 1.05 (95% confidence interval = 0.57-1.9). Using an alternative, less sensitive definition of PID gave a risk ratio of 1.26 (0.62-2.6). The probability of becoming pregnant was 15% lower among women assigned to use a douche product, and 33% lower among women who douched more frequently (ratio = 0.67; 0.42-1.08).
CONCLUSIONS: There was little or no indication of a greater risk of PID among women assigned to use the douche product. Douching may be related to a lower probability that a woman becomes pregnant.

Entities:  

Mesh:

Year:  2003        PMID: 12859036

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  8 in total

1.  Variation and predictors of vaginal douching behavior.

Authors:  Dawn P Misra; Britton Trabert; Shelly Atherly-Trim
Journal:  Womens Health Issues       Date:  2006 Sep-Oct

2.  Prevalence and correlates of recent vaginal douching among African American adolescent females.

Authors:  R J Diclemente; A M Young; J L Painter; G M Wingood; E Rose; J M Sales
Journal:  J Pediatr Adolesc Gynecol       Date:  2011-11-03       Impact factor: 1.814

Review 3.  Candidiasis (vulvovaginal).

Authors:  Des Spence
Journal:  BMJ Clin Evid       Date:  2010-01-05

4.  Inhibitory effect of Lactobacillus gasseri CCFM1201 on Gardnerella vaginalis in mice with bacterial vaginosis.

Authors:  Qiuxiang Zhang; Qiuhan Cheng; Shumao Cui; Jianxin Zhao; Wei Chen; Hao Zhang
Journal:  Arch Microbiol       Date:  2022-05-11       Impact factor: 2.552

5.  Intravaginal practices and genital human papillomavirus infection among female sex workers in Cambodia.

Authors:  Thanh Cong Bui; Michael E Scheurer; Vy Thi-Tuong Pham; Ly Thi-Hai Tran; Leng Bun Hor; Damon J Vidrine; Michael W Ross; Christine M Markham
Journal:  J Med Virol       Date:  2018-08-13       Impact factor: 2.327

6.  Saccharomyces cerevisiae-based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis.

Authors:  Samuele Sabbatini; Claudia Monari; Nathalie Ballet; Paolo Mosci; Amélie Cayzeele Decherf; Fanny Pélerin; Stefano Perito; Paolo Scarpelli; Anna Vecchiarelli
Journal:  Virulence       Date:  2018-12-31       Impact factor: 5.882

7.  Association of bacterial vaginosis with periodontitis in a cross-sectional American nationwide survey.

Authors:  Cláudia Escalda; João Botelho; José João Mendes; Vanessa Machado
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

Review 8.  Bacterial Vaginosis Biofilms: Challenges to Current Therapies and Emerging Solutions.

Authors:  Daniela Machado; Joana Castro; Ana Palmeira-de-Oliveira; José Martinez-de-Oliveira; Nuno Cerca
Journal:  Front Microbiol       Date:  2016-01-20       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.